Ingo Schmitz

15.3k total citations · 2 hit papers
112 papers, 5.2k citations indexed

About

Ingo Schmitz is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Ingo Schmitz has authored 112 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 48 papers in Immunology and 18 papers in Cancer Research. Recurrent topics in Ingo Schmitz's work include Cell death mechanisms and regulation (36 papers), Immune Cell Function and Interaction (18 papers) and NF-κB Signaling Pathways (16 papers). Ingo Schmitz is often cited by papers focused on Cell death mechanisms and regulation (36 papers), Immune Cell Function and Interaction (18 papers) and NF-κB Signaling Pathways (16 papers). Ingo Schmitz collaborates with scholars based in Germany, United States and France. Ingo Schmitz's co-authors include Peter H. Krammer, Marcus E. Peter, Carsten Scaffidi, Sabine Kirchhoff, Andreas Krueger, Klaus Schulze‐Osthoff, Sven Baumann, Marc Schuster, Jiping Zha and Stanley J. Korsmeyer and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Ingo Schmitz

107 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of c-FLIP in Modulation of CD95-induced Apoptosis

1999 687 citations Ingo Schmitz, Peter H. Krammer et al. profile →
Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells

1999 523 citations Ingo Schmitz, Peter H. Krammer et al. profile →

Peers

Countries citing papers authored by Ingo Schmitz

Since Specialization

Citations

This map shows the geographic impact of Ingo Schmitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Schmitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Schmitz more than expected).

Fields of papers citing papers by Ingo Schmitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingo Schmitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Schmitz. The network helps show where Ingo Schmitz may publish in the future.

Co-authorship network of co-authors of Ingo Schmitz

This figure shows the co-authorship network connecting the top 25 collaborators of Ingo Schmitz. A scholar is included among the top collaborators of Ingo Schmitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingo Schmitz. Ingo Schmitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ACC1 is a dual metabolic-epigenetic regulator of Treg stability and immune tolerance 2025 ·Molecular Metabolism ·Philipp Stüve, (unknown), (unknown), (unknown), Fatima Boukhallouk, (unknown), Tushar H. More, (unknown), Tatiana Akimova, Wolf‐Rainer Abraham, Volkhard Kaever, Ingo Schmitz, Karsten Hiller, Matthias Lochner, Benoı̂t L. Salomon, Ulf H. Beier, Michael Rehli, Tim Sparwasser, Luciana Berod	8
2	The nuclear GYF protein CD2BP2/U5–52K is required for T cell homeostasis 2024 ·Frontiers in Immunology ·(unknown), (unknown), Carlos Plaza‐Sirvent, Marc Schuster, Marco Preußner, Benno Kuropka, Fan Liu, (unknown), (unknown), Benjamin König, Miguel Álvaro‐Benito, Esam T. Abualrous, (unknown), Stefanie Kliche, (unknown), Ingo Schmitz, Christian Freund	2
3	The atypical IκB family member Bcl3 determines differentiation and fate of intestinal RORγt+ regulatory T-cell subsets 2024 ·Mucosal Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mária Pásztói, (unknown), (unknown), (unknown), Tilo Biedermann, Ingo Schmitz, Wiebke Hansen, Daniela Kramer, Matthias M. Gaida, Carsten B. Schmidt‐Weber, (unknown), Caspar Ohnmacht	2
4	Immunophenotyping of Monocyte Migration Markers and Therapeutic Effects of Selenium on IL-6 and IL-1β Cytokine Axes of Blood Mononuclear Cells in Preoperative and Postoperative Coronary Artery Disease Patients 2023 ·International Journal of Molecular Sciences ·Max Wacker, Anna Ball, Hans‐Dietmar Beer, Ingo Schmitz, Katrin Borucki, (unknown), Maximilian Scherner, George Awad, Jens Wippermann, (unknown)	4
5	Preserved T-cell response in anti-CD20-treated multiple sclerosis patients following SARS-CoV-2 vaccination 2022 ·Therapeutic Advances in Neurological Disorders ·Simon Faissner, (unknown), (unknown), (unknown), (unknown), Carlos Plaza‐Sirvent, (unknown), (unknown), Ilya Ayzenberg, Kerstin Hellwig, Ingo Schmitz, Stephanie Pfaender, Ralf Gold	3
6	Y192 within the SH2 Domain of Lck Regulates TCR Signaling Downstream of PLC-γ1 and Thymic Selection 2022 ·International Journal of Molecular Sciences ·(unknown), (unknown), Roland Hartig, Carlos Plaza‐Sirvent, Ingo Schmitz, Ursula Bommhardt, Burkhart Schraven, Luca Simeoni	6
7	Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV 2022 ·Frontiers in Immunology ·(unknown), Carlos Plaza‐Sirvent, (unknown), Jaydeep Bhat, (unknown), Doris Urlaub, (unknown), (unknown), (unknown), (unknown), Adriane Skaletz‐Rorowski, Norbert H. Brockmeyer, (unknown), Anke Reinacher‐Schick, Simon Faissner, Carsten Watzl, Stephanie Pfaender, Anja Potthoff, Ingo Schmitz	11
8	Autophagy—A Story of Bacteria Interfering with the Host Cell Degradation Machinery 2021 ·Pathogens ·(unknown), Sabrina Mühlen, (unknown), Ingo Schmitz	33
9	A Central Role for Atg5 in Microbiota-Dependent Foxp3+ RORγt+ Treg Cell Preservation to Maintain Intestinal Immune Homeostasis 2021 ·Frontiers in Immunology ·Carlos Plaza‐Sirvent, Bei Zhao, (unknown), Marina C. Pils, (unknown), Marc Schuster, Till Strowig, Ingo Schmitz	7
10	Sensor system for long-term analysis of fuel vapour restraint systems 2020 ·tm - Technisches Messen ·(unknown), (unknown), (unknown), Ulrich Göbel, Ingo Schmitz, Jürgen Keller, Thomas Seeger	1
11	Essential role of IκB _NS for in vivo CD4 ⁺ T‐cell activation, proliferation, and Th1‐cell differentiation during Listeria monocytogenes infection in mice 2019 ·European Journal of Immunology ·(unknown), Konstantinos Katsoulis‐Dimitriou, Andreas Jeron, Ingo Schmitz, Dunja Bruder	9
12	Acute cytotoxicity of MIRA-1/NSC19630, a mutant p53-reactivating small molecule, against human normal and cancer cells via a caspase-9-dependent apoptosis 2015 ·Cancer Letters ·Chantal Bou‐Hanna, Anne Jarry, Laurence Lodé, Ingo Schmitz, Klaus Schulze‐Osthoff, Sébastien Küry, Stéphane Bezieau, Jean‐François Mosnier, Christian Laboisse	38
13	Multiple Mechanisms Mediate Resistance to Sorafenib in Urothelial Cancer 2014 ·International Journal of Molecular Sciences ·(unknown), Wolfgang A. Schulz, (unknown), Christiane Hader, (unknown), Ingo Schmitz, Peter Albers, Günter Niegisch	21
14	Constitutive expression of murine c-FLIPR causes autoimmunity in aged mice 2014 ·Cell Death and Disease ·(unknown), (unknown), Marina C. Pils, Carlos Plaza‐Sirvent, Frauke Neff, Christian Erck, Dirk Reinhold, Ingo Schmitz	6
15	I kappa B zeta Is a Transcriptional Key Regulator of CCL2/MCP-1 2013 ·The Journal of Immunology ·Dominic G. Hildebrand, Eva Alexander, (unknown), Simon Lehle, (unknown), (unknown), Oliver C. Rothfuss, Julia-Stefanie Frick, Masami Morimatsu, Ingo Schmitz, (unknown), Jan Ehrchen, Frank Eßmann, Klaus Schulze‐Osthoff	3
16	Inhibition of autophagy through MAPK14-mediated phosphorylation of ATG5 2012 ·Autophagy ·(unknown), (unknown), Ingo Schmitz	22
17	Resistance of Short Term Activated T Cells to CD95-Mediated Apoptosis Correlates with De Novo Protein Synthesis of c-FLIPshort 2004 ·The Journal of Immunology ·Ingo Schmitz, Heiko Weyd, Andreas Krueger, Sven Baumann, Stefanie C. Fas, Peter H. Krammer, Sabine Kirchhoff	72
18	An IL-2-Dependent Switch Between CD95 Signaling Pathways Sensitizes Primary Human T Cells Toward CD95-Mediated Activation-Induced Cell Death 2003 ·The Journal of Immunology ·Ingo Schmitz, Andreas Krueger, Sven Baumann, Henning Schulze‐Bergkamen, Peter H. Krammer, Sabine Kirchhoff	54
19	Gene expression analysis of thymocyte selection in vivo 2003 ·International Immunology ·Ingo Schmitz	41
20	TCR-Mediated Up-Regulation of c-FLIPshort Correlates with Resistance Toward CD95-Mediated Apoptosis by Blocking Death-Inducing Signaling Complex Activity 2000 ·The Journal of Immunology ·Sabine Kirchhoff, Wolfgang W. Müller, Andreas Krueger, Ingo Schmitz, Peter H. Krammer	109

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact